wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38204368-ECE806B4-79BD-4D88-A9ED-FE76918988EA
Q38204368-ECE806B4-79BD-4D88-A9ED-FE76918988EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38204368-ECE806B4-79BD-4D88-A9ED-FE76918988EA
Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir.
P698
Q38204368-ECE806B4-79BD-4D88-A9ED-FE76918988EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38204368-ECE806B4-79BD-4D88-A9ED-FE76918988EA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
beb65c07226a0842ec36ee849f0734209ff5329a
P698
24729731
http://www.w3.org/2001/XMLSchema#string